These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 2858951
1. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)]. Arushanian EB. Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951 [No Abstract] [Full Text] [Related]
2. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P, Bathien N. Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
3. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. Bitton V, Melamed E. J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157 [Abstract] [Full Text] [Related]
4. Tardive dyskinesia: a role for the endogenous opioid system. Sandyk R. Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480 [Abstract] [Full Text] [Related]
6. Constraints on inferring neurochemical involvement in behavior. Dismukes RK. Neurosci Res Program Bull; 1978 Dec; 16(4):580-4. PubMed ID: 35765 [No Abstract] [Full Text] [Related]
7. Neurotransmitter interactions related to central dopamine neurons. Lloyd KG. Essays Neurochem Neuropharmacol; 1978 Dec; 3():129-207. PubMed ID: 30628 [No Abstract] [Full Text] [Related]
8. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. Hansen TE, Brown WL, Weigel RM, Casey DE. J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762 [Abstract] [Full Text] [Related]
9. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment. Casey DE, Povlsen UJ, Meidahl B, Gerlach J. Psychopharmacol Bull; 1986 Apr; 22(1):250-3. PubMed ID: 2873612 [No Abstract] [Full Text] [Related]
10. Coexisting tardive dyskinesia and parkinsonism: a case report. De Fraites EG, Davis KL, Berger PA. Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938 [Abstract] [Full Text] [Related]
11. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances]. Arushanian EB. Usp Fiziol Nauk; 1979 Apr; 10(2):45-72. PubMed ID: 38580 [No Abstract] [Full Text] [Related]
12. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters. Hassler R. Int J Neurol; 1979 Apr; 13(1-4):94-116. PubMed ID: 45452 [No Abstract] [Full Text] [Related]
13. Neuroleptic drugs and their action on different neuronal pathways. Ungerstedt U, Herrera-Marschitz M, Forster C. J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478 [Abstract] [Full Text] [Related]
18. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients. Grimes JD. Can Med Assoc J; 1982 Mar 01; 126(5):468. PubMed ID: 6121618 [No Abstract] [Full Text] [Related]
19. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Bishnoi M, Chopra K, Kulkarni SK. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):451-61. PubMed ID: 17988775 [Abstract] [Full Text] [Related]
20. [Changes in functional interrelations of neuromediator systems during aging and the development of neuropsychological pathology of old age (review)]. Burchinskiĭ SG. Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Feb 15; 85(9):1394-1400. PubMed ID: 2866651 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]